Acquired inhibitors in nonhemophilic patients.
D001172:Arthritis, Rheumatoid / Q000097:blood; D001379:Azathioprine / Q000627:therapeutic use; D001778:Blood Coagulation Disorders; D001780:Blood Coagulation Tests; D001796:Blood Protein Disorders / Q000097:blood; D003872:Dermatitis / Q000097:blood; D004342:Drug Hypersensitivity / Q000097:blood; D004789:Enzyme Activation; D005078:Exchange Transfusion, Whole Blood; D005164:Factor IX; D005165:Factor V; D005169:Factor VIII / Q000627:therapeutic use; D005170:Factor X; D005176:Factor XIII; D005260:Female; D006474:Hemorrhagic Disorders / Q000209:etiology; D006801:Humans; D006967:Hypersensitivity / Q000097:blood; D007020:Hypoprothrombinemias / Q000097:blood; D008180:Lupus Erythematosus, Systemic / Q000097:blood; D010392:Pemphigus / Q000097:blood; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic; D013256:Steroids / Q000627:therapeutic use; D014842:von Willebrand Diseases / Q000097:blood
D013256:Steroids; D005165:Factor V; D005169:Factor VIII; D005164:Factor IX; D005170:Factor X; D005176:Factor XIII; D001379:Azathioprine